_version_ 1784648088720244736
author Paraskevas, Kosmas I.
Mikhailidis, Dimitri P.
Baradaran, Hediyeh
Davies, Alun H.
Eckstein, Hans-Henning
Faggioli, Gianluca
Fernandes, Jose Fernandes e
Gupta, Ajay
Jezovnik, Mateja K.
Kakkos, Stavros K.
Katsiki, Niki
Kooi, M. Eline
Lanza, Gaetano
Liapis, Christos D.
Loftus, Ian M.
Millon, Antoine
Nicolaides, Andrew N.
Poredos, Pavel
Pini, Rodolfo
Ricco, Jean-Baptiste
Rundek, Tatjana
Saba, Luca
Spinelli, Francesco
Stilo, Francesco
Sultan, Sherif
Zeebregts, Clark J.
Chaturvedi, Seemant
author_facet Paraskevas, Kosmas I.
Mikhailidis, Dimitri P.
Baradaran, Hediyeh
Davies, Alun H.
Eckstein, Hans-Henning
Faggioli, Gianluca
Fernandes, Jose Fernandes e
Gupta, Ajay
Jezovnik, Mateja K.
Kakkos, Stavros K.
Katsiki, Niki
Kooi, M. Eline
Lanza, Gaetano
Liapis, Christos D.
Loftus, Ian M.
Millon, Antoine
Nicolaides, Andrew N.
Poredos, Pavel
Pini, Rodolfo
Ricco, Jean-Baptiste
Rundek, Tatjana
Saba, Luca
Spinelli, Francesco
Stilo, Francesco
Sultan, Sherif
Zeebregts, Clark J.
Chaturvedi, Seemant
author_sort Paraskevas, Kosmas I.
collection PubMed
description
format Online
Article
Text
id pubmed-8829475
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Korean Stroke Society
record_format MEDLINE/PubMed
spelling pubmed-88294752022-02-18 Optimal Management of Asymptomatic Carotid Stenosis: Counterbalancing the Benefits with the Potential Risks Paraskevas, Kosmas I. Mikhailidis, Dimitri P. Baradaran, Hediyeh Davies, Alun H. Eckstein, Hans-Henning Faggioli, Gianluca Fernandes, Jose Fernandes e Gupta, Ajay Jezovnik, Mateja K. Kakkos, Stavros K. Katsiki, Niki Kooi, M. Eline Lanza, Gaetano Liapis, Christos D. Loftus, Ian M. Millon, Antoine Nicolaides, Andrew N. Poredos, Pavel Pini, Rodolfo Ricco, Jean-Baptiste Rundek, Tatjana Saba, Luca Spinelli, Francesco Stilo, Francesco Sultan, Sherif Zeebregts, Clark J. Chaturvedi, Seemant J Stroke Letter to the Editor Korean Stroke Society 2022-01 2022-01-31 /pmc/articles/PMC8829475/ /pubmed/35135072 http://dx.doi.org/10.5853/jos.2021.04420 Text en Copyright © 2022 Korean Stroke Society https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Paraskevas, Kosmas I.
Mikhailidis, Dimitri P.
Baradaran, Hediyeh
Davies, Alun H.
Eckstein, Hans-Henning
Faggioli, Gianluca
Fernandes, Jose Fernandes e
Gupta, Ajay
Jezovnik, Mateja K.
Kakkos, Stavros K.
Katsiki, Niki
Kooi, M. Eline
Lanza, Gaetano
Liapis, Christos D.
Loftus, Ian M.
Millon, Antoine
Nicolaides, Andrew N.
Poredos, Pavel
Pini, Rodolfo
Ricco, Jean-Baptiste
Rundek, Tatjana
Saba, Luca
Spinelli, Francesco
Stilo, Francesco
Sultan, Sherif
Zeebregts, Clark J.
Chaturvedi, Seemant
Optimal Management of Asymptomatic Carotid Stenosis: Counterbalancing the Benefits with the Potential Risks
title Optimal Management of Asymptomatic Carotid Stenosis: Counterbalancing the Benefits with the Potential Risks
title_full Optimal Management of Asymptomatic Carotid Stenosis: Counterbalancing the Benefits with the Potential Risks
title_fullStr Optimal Management of Asymptomatic Carotid Stenosis: Counterbalancing the Benefits with the Potential Risks
title_full_unstemmed Optimal Management of Asymptomatic Carotid Stenosis: Counterbalancing the Benefits with the Potential Risks
title_short Optimal Management of Asymptomatic Carotid Stenosis: Counterbalancing the Benefits with the Potential Risks
title_sort optimal management of asymptomatic carotid stenosis: counterbalancing the benefits with the potential risks
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829475/
https://www.ncbi.nlm.nih.gov/pubmed/35135072
http://dx.doi.org/10.5853/jos.2021.04420
work_keys_str_mv AT paraskevaskosmasi optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT mikhailidisdimitrip optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT baradaranhediyeh optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT daviesalunh optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT ecksteinhanshenning optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT faggioligianluca optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT fernandesjosefernandese optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT guptaajay optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT jezovnikmatejak optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT kakkosstavrosk optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT katsikiniki optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT kooimeline optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT lanzagaetano optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT liapischristosd optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT loftusianm optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT millonantoine optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT nicolaidesandrewn optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT poredospavel optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT pinirodolfo optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT riccojeanbaptiste optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT rundektatjana optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT sabaluca optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT spinellifrancesco optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT stilofrancesco optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT sultansherif optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT zeebregtsclarkj optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks
AT chaturvediseemant optimalmanagementofasymptomaticcarotidstenosiscounterbalancingthebenefitswiththepotentialrisks